SBT 16th Annual Meeting


1 | 2 | 3 | 4 | 5 | 6 | 7

1 Monitoring Stem Cell Therapy In Vivo
J.W.M. Bulte, T. Douglas, B. Witwer, S-C. Zhang, B.K. Lewis, P.van Gelderen, I.D. Duncan, J.A. Frank.
Laboratory of Diagnostic Radiology Research (CC), National Institutes of Health, Bethesda, MD
2 Dendritic Cell-Tumor Fusions As Immunotherapy: A Phase I Clinical Trial in Patients with Metastatic Renal Cancer
Avigan, David1; Atkins, Michael1; Gong, Jianling1; Uhl, Lynne1; Smith, Therese1; Wu, Zekui2; Vasir, Baldev2; Mier, James1; Gollob, Jared1; McDermott, David1; Borges, Virginia1; Stone, Carolyn1; Schadt, Kimberly1; Tetreault, Jean Claude1; Kufe, Donald2
1Hematology Oncology, Beth Israel Deaconess Medical Center Boston, MA; 2Adult Oncology, Dana Farber Cancer Institute Boston, MA
3 Poly(ADP-Ribose) Polymerase Role in the Repair of Topoisomerase L -Induced DNA Damage
JM Barceló1, G Kholhagen1, A van Hattum1, CM Simbulan-Rosenthal2,ME Smulson2,Y Pommier1
1Laboratory of Molecular Pharmacology, CCR, NCI, NIH; 2Department of Biochemistry and Molecular Biology, Georgetown University School of Medicine, Washington DC
4 Elimination of well-established metastases by adoptively transferred, IL2-activated NK (A-NK) correlates with their ability to localize to the malignant tissue
Basse, Per; Yang, Yuqing; Herberman, Ronald
University of Pittsburgh Cancer Institute, Pittsburgh, PA
5 Preferential apoptosis of CD56+dim natural killer cell subset in patients with cancer
Thomas Bauernhofer, Iris Kuss, Brent Henderson, Andrew S. Baum, Theresa L. Whiteside
University of Pittsburgh Cancer Institute, Pittsburgh, PA
6 Higher onset of apoptosis of circulating T-lymphocytes does not correlate with prolactin receptor expression and prolactin plasma levels in patients with breast cancer
Thomas Bauernhofer, Ulrike Friebe-Hoffmann, Grzegorz Dworacki, Barbara Vonderhaar, Andrew S. Baum, Theresa L. Whiteside
University of Pittsburgh Cancer Institute, Pittsburgh, PA and NCI, NIH, Bethesda, MD
7 Human U251-MG Glioma Cells Expressing the Membrane Form of Macrophage Colony Stimulating Factor (mM-CSF) are Killed by Human Monocytes In Vitro and Are Rejected in Immunodeficient Mice
Chen Y, Jadus MR, Lloyd C, Sanchez R, Delgado C, Wepsic HT
Diagnostic and Molecular Medicine Health Care Group, Veterans Affairs Medical Center, Long Beach, CA; Pathology Department, University of California, Irvine, CA
8 Apo2-L/TRAIL-induced apoptosis in 4 leukemic cell lines is not enhanced by hyperthermia in vitro
Jinrong Cheng, Elizabeth Repasky
Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY
9 Characterization of autologous activated lymphocytes used for adoptive immunotherapy of renal cell and colon carcinoma
Cornforth, AN, Schiltz PM, Nayak SK, Dillman RO
Hoag Cancer Center, Newport Beach, CA
10 Murine Hepatoma Hepa1-6 cells Expressing the Membrane Form of Macrophage Colony Stimulating Factor (mM-CSF) are Killed by Macrophages In Vitro and Lead to Tumor Rejection and Immunization Against the Parental Tumor In Vivo by CD8+ T Cells
Dan Q, Wepsic HT, Morgan K, Sanchez R, Morgan TR, Jadus MR
Veterans Affairs Medical Center Long Beach CA and University of California Irvine
11 4T1 Mammary Tumor Suppresses B- and T-cell Function In Vivo
Erika A. Danna, Beth A. Pulaski, Mileka Gilbert, and Suzanne Ostrand-Rosenberg
Department of Biological Sciences, University of Maryland Baltimore County, Baltimore, MD
12 Delayed type hypersensitivity skin testing with irradiated autologous tumor cells: association with survival during treatment with autologous tumor cell vaccine
Dillman RO, DePriest C, Beutel LD, Barth NM, de Leon C, O’Connor A, Nayak SK
Hoag Cancer Center, Newport Beach, CA